OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00221559

Shenzhen Noposion Crop Science Co Ltd

Agricultural ChemicalsVerified

The company maintains a debt-to-equity ratio of 1.28, indicating a moderate reliance on debt financing, and a current ratio of 0.75, suggesting potential liquidity constraints in the short term. Free cash flow is negative at -410.7 million CNY, and capital expenditures are significant at -1.24 billion CNY, reflecting ongoing investment in operations. The return on equity is 15.63%, and return on assets is 5.48%, both above the industry median for agricultural chemicals, indicating strong profitability relative to its asset base. Profitability metrics show that the company generates a gross profit of 2.15 billion CNY and an operating income of 667.4 million CNY, with a net income of 650.4 million CNY. These figures suggest a healthy margin structure, particularly when compared to the industry median for agricultural chemicals. The company's return on equity and return on assets are both above the industry average, indicating efficient use of equity and assets to generate returns. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks. The company's revenue is primarily derived from the sale of crop protection products, with no material diversification into other chemical or agricultural product lines. Outlook for the current fiscal year shows a projected growth in revenue and net income, with analysts forecasting a mean price target of 13.80 CNY. The company's capital expenditures are expected to remain high, reflecting ongoing investment in production capacity and R&D. The company's free cash flow is expected to remain negative in the near term, but operating cash flow is strong at 1.48 billion CNY, indicating the ability to service debt and fund operations. The company faces moderate liquidity risk due to a current ratio below 1 and a negative net cash position after subtracting total debt. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. The company's debt structure is primarily long-term, with 5.31 billion CNY in long-term debt, and no material dilution sources identified in recent filings. Recent filings and transcripts indicate that the company is focused on expanding its product portfolio and geographic reach. The company has also emphasized R&D investment to develop new crop protection solutions. No material legal or regulatory issues have been disclosed in the latest filings, and the ESG controversies score is 100.00, indicating no recent controversies.

30-day price · 002215-0.45 (-4.4%)
Low$9.68High$11.04Close$9.82As of19 May, 00:00 UTC
Profile
CompanyShenzhen Noposion Crop Science Co Ltd
Ticker002215.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryAgricultural Chemicals
AI analysis

Business. Shenzhen Noposion Crop Science Co Ltd is an agricultural chemicals company that produces and sells crop protection products, primarily pesticides and herbicides, to the global agrochemical market.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Agricultural Chemicals industry with a confidence level of 0.92.

The company maintains a debt-to-equity ratio of 1.28, indicating a moderate reliance on debt financing, and a current ratio of 0.75, suggesting potential liquidity constraints in the short term. Free cash flow is negative at -410.7 million CNY, and capital expenditures are significant at -1.24 billion CNY, reflecting ongoing investment in operations. The return on equity is 15.63%, and return on assets is 5.48%, both above the industry median for agricultural chemicals, indicating strong profitability relative to its asset base. Profitability metrics show that the company generates a gross profit of 2.15 billion CNY and an operating income of 667.4 million CNY, with a net income of 650.4 million CNY. These figures suggest a healthy margin structure, particularly when compared to the industry median for agricultural chemicals. The company's return on equity and return on assets are both above the industry average, indicating efficient use of equity and assets to generate returns. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic and regulatory risks. The company's revenue is primarily derived from the sale of crop protection products, with no material diversification into other chemical or agricultural product lines. Outlook for the current fiscal year shows a projected growth in revenue and net income, with analysts forecasting a mean price target of 13.80 CNY. The company's capital expenditures are expected to remain high, reflecting ongoing investment in production capacity and R&D. The company's free cash flow is expected to remain negative in the near term, but operating cash flow is strong at 1.48 billion CNY, indicating the ability to service debt and fund operations. The company faces moderate liquidity risk due to a current ratio below 1 and a negative net cash position after subtracting total debt. Dilution risk is low, with no near-term pressure from share issuance or convertible debt. The company's debt structure is primarily long-term, with 5.31 billion CNY in long-term debt, and no material dilution sources identified in recent filings. Recent filings and transcripts indicate that the company is focused on expanding its product portfolio and geographic reach. The company has also emphasized R&D investment to develop new crop protection solutions. No material legal or regulatory issues have been disclosed in the latest filings, and the ESG controversies score is 100.00, indicating no recent controversies.
Key takeaways
  • The company has a strong return on equity and return on assets, indicating efficient use of capital.
  • Free cash flow is negative, but operating cash flow is robust, supporting debt servicing and operations.
  • The company's revenue is concentrated in a single business segment, increasing exposure to market and regulatory risks.
  • Analysts have a consistent price target of 13.80 CNY, suggesting a stable outlook for the stock.
  • The company's debt structure is primarily long-term, with no material dilution risk in the near term.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$5.78B
Gross profit$2.15B
Operating income$667.4M
Net income$650.4M
R&D
SG&A
D&A
SBC
Operating cash flow$1.48B
CapEx-$1.24B
Free cash flow-$410.7M
Total assets$11.87B
Total liabilities$7.71B
Total equity$4.16B
Cash & equivalents
Long-term debt$5.31B
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$4.16B
Net cash-$5.31B
Current ratio0.8
Debt/Equity1.3
ROA5.5%
ROE15.6%
Cash conversion2.3%
CapEx/Revenue-21.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002215Activity
Op margin11.5%0.4% medp25 -8.0% · p75 16.0%above median
Net margin11.2%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin37.1%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-21.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity128.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Mean price target13.80 CNY
Median price target13.80 CNY
High price target13.80 CNY
Low price target13.80 CNY
Social pillar1.18 (0-100)
Governance pillar32.19 (0-100)
ESG controversies score100.00 (0-100, higher = fewer controversies)
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 00:29 UTCJob: 7b27b3ac